INGRID SHARPE: Open Payments
NPI 1144619784 · SIMI VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$588 in 25 payments from 7 companies in 2025. Trend: 2023 $233 · 2024 $259 · 2025 $588
Food & beverage: $588
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $335 |
| Alkermes, Inc. | 2 | $60 |
| Abbott Laboratories | 1 | $51 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $43 |
| Vanda Pharmaceuticals Inc. | 1 | $31 |
| Amgen Inc. | 1 | $24 |
Products named: QULIPTA, VRAYLAR, UBRELVY, ID NOW INSTRUMENT, Auvelity, CAPLYTA, VIVITROL, FANAPT.
Industry payments across CA — which companies pay providers there.
